Casdin Amplify Fund, LP - 18 Jun 2024 Form 3 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: Director
Signature: Casdin Amplify Fund, LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member
Issuer symbol: LAB
Transactions as of: 18 Jun 2024
Net transactions value: $0
Form type: 3
Filing time: 26 Jun 2024, 20:08:37 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LAB	Common Stock						545,000	18 Jun 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Amplify ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of Amplify (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.

Remarks:

Eli Casdin has been deputized to represent the Reporting Person on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), the Reporting Person may be deemed a director by deputization of the Issuer. The Reporting Person disclaims beneficial ownership in the securities reported on this Form 3 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.